[The Exploration of Extrapolation of Data from Adults to Pediatric Population]

Lu Liu1, Xinyue Cui1, Yujing Zhang1

  • 1Center for Medical Device Evaluation, NMPA, Beijing, 100081.

Insights

Extrapolating adult medical device data to pediatric populations can address unmet needs and reduce clinical trials. This approach accelerates pediatric device development and ensures availability for children.

Area of Science:

  • Biomedical Engineering
  • Pediatric Medical Device Development
  • Regulatory Science

Background:

  • Existing pediatric medical devices are insufficient to meet current clinical demands.
  • Conducting clinical trials in pediatric populations presents significant challenges.
  • There is a critical need for efficient pathways to develop and approve pediatric medical devices.

Purpose of the Study:

  • To address the unmet needs in pediatric medical devices.
  • To explore the feasibility and benefits of extrapolating adult medical device data to pediatric use.
  • To provide insights for improving pediatric data extrapolation in China.

Main Methods:

  • Analysis of regulatory guiding principles in the United States for medical device data extrapolation.
  • Evaluation of medical device technology from a data extrapolation perspective for the pediatric population in China.
  • Comparative review of international approaches to pediatric data extrapolation.

Main Results:

  • Extrapolation of adult data can maximize existing evidence and minimize redundant pediatric clinical trials.
  • This strategy can expedite the development and market access of pediatric medical devices.
  • It ensures that critical pediatric device demands are met more effectively.

Conclusions:

  • Reasonable extrapolation of adult medical device data is a viable strategy for pediatric populations.
  • Implementing robust data extrapolation frameworks can significantly benefit pediatric healthcare.
  • This approach offers a valuable reference for advancing medical device technology evaluation and regulation in China.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
224
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
641
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
184
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
210
Data Collection by Experiments01:13

Data Collection by Experiments

Data collection is a systematic method of obtaining, observing, measuring, and analyzing accurate information. An experimental study is a standard method of data collection that involves the manipulation of the samples by applying some form of treatment prior to data collection. It refers to manipulating one variable to determine its changes on another variable. The sample subjected to treatment is known as “experimental units.”
An example of the experimental method is a public...
26.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
227